Perindopril metabolic effects and organo-protective action in metabolic syndrome patients
Autor: | V. B. Mychka, V. P. Masenko, N. V. Flegontova, D. M. Ataullakhanova, V. B. Sergienko, I. E. Chazova |
---|---|
Jazyk: | ruština |
Rok vydání: | 2007 |
Předmět: | |
Zdroj: | Кардиоваскулярная терапия и профилактика, Vol 6, Iss 2, Pp 34-41 (2007) |
Druh dokumentu: | article |
ISSN: | 1728-8800 2619-0125 |
Popis: | Aim. To assess perindopril antihypertensive effects and its influence on metabolic disturbances, myocardial structure, and cerebral perfusion (CP) in patients with mild to moderate arterial hypertension (AH) and metabolic syndrome (MS) (AH + MS). Material and methods. Thirty patients with mild to moderate AH + MS participated in the study. At baseline and 24 weeks later, 24-hour blood pressure monitoring (BPM), carbohydrate and lipid metabolism, insulin sensitivity, myocardial structure and function, as well as CP parameters were assessed. Results. Target BP levels were achieved in 70% of the patients receiving perindopril: 9 and 21 patients were administered 4 and 8 mg/d, respectively. Fasting and postprandial glucose levels decreased significantly (both p |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |